ON DEMAND WEBINAR
Duration: 1 hour
While cell and gene therapies promise to revolutionize the worlds of rare disease, oncology and CNS disorders, these novel therapeutics are expensive, time-consuming and extremely manual and iterative to manufacture and scale. New genomics technologies are poised to allow for streamlined manufacturing to increase efficiency and decrease time to market and financial investment.
Register for this webinar and join Form Bio’s Head of Solutions Science, Alpha Diallo, PhD, and PacBio’s Associate Director of Product Marketing, Elizabeth Tseng, PhD to learn about next-gen cell and gene therapy manufacturing. Learn how PacBio's AAV vectors sequencing combined with Form Bio's computational workflows that build on PacBio AAV data mean optimized AAV design work and shorter timelines for leaders in novel therapeutic manufacturing. This webinar includes discussions of:
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again